Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -609,693 | -436,349 | -262,372 | -135,376 | -209,275 |
| Depreciation Amortization | 15,351 | 21,456 | 9,684 | 3,428 | 10,476 |
| Accounts receivable | N/A | N/A | 0 | N/A | 1,410 |
| Accounts payable and accrued liabilities | -5,536 | 2,785 | -8,402 | -12,463 | 32,998 |
| Other Working Capital | 25,091 | 17,139 | -7,505 | -10,873 | -51,547 |
| Other Operating Activity | 111,936 | 69,334 | 58,378 | 37,444 | 62,048 |
| Operating Cash Flow | $-462,851 | $-325,635 | $-210,217 | $-117,840 | $-153,890 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -720,947 | -428,611 | 208,615 | 133,495 | -246,141 |
| PPE Investments | -141,469 | -117,180 | -102,731 | -68,656 | -176,737 |
| Purchase Of Investment | N/A | N/A | -309,982 | N/A | N/A |
| Sale Of Investment | 442,344 | 348,642 | N/A | N/A | 326,723 |
| Investing Cash Flow | $-420,072 | $-197,149 | $-204,098 | $64,839 | $-96,155 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 392,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 431,654 | 431,431 | 431,044 | 267 | 3,053 |
| Other Financing Activity | 46,866 | 50,000 | 0 | 0 | 250,000 |
| Financing Cash Flow | $870,520 | $481,431 | $431,044 | $267 | $253,053 |
| Exchange Rate Effect | 4,197 | -139 | 84 | 58 | -122 |
| Beginning Cash Position | 110,891 | 110,891 | 110,891 | 110,891 | 108,005 |
| End Cash Position | 102,685 | 69,399 | 127,704 | 58,215 | 110,891 |
| Net Cash Flow | $-8,206 | $-41,492 | $16,813 | $-52,676 | $2,886 |
| Free Cash Flow | |||||
| Operating Cash Flow | -462,851 | -325,635 | -210,217 | -117,840 | -153,890 |
| Capital Expenditure | -141,469 | -117,180 | -102,731 | -68,656 | -176,737 |
| Free Cash Flow | -604,320 | -442,815 | -312,948 | -186,496 | -330,627 |